▶ 調査レポート

世界の出血性神経介入装置市場予測(~2028年):コイル塞栓システム、ニューロインターベンションローダイバーティングステント、その他

• 英文タイトル:Global Hemorrhagic Neurointerventional Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の出血性神経介入装置市場予測(~2028年):コイル塞栓システム、ニューロインターベンションローダイバーティングステント、その他 / Global Hemorrhagic Neurointerventional Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 / GIR-22F17838資料のイメージです。• レポートコード:GIR-22F17838
• 出版社/出版日:GlobalInfoResearch / 2022年11月
• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「Global Hemorrhagic Neurointerventional Device Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
グローバルインフォリサーチ社の最新の調査によると、世界の出血性神経介入装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

出血性神経介入装置市場はタイプ(種類)とアプリケーション(用途)によって区分されます。2017年~2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・コイル塞栓システム、ニューロインターベンションローダイバーティングステント、その他

アプリケーション別セグメントは次のように区分されます。
・病院・診療所、外来手術センター、その他

世界の出血性神経介入装置市場の主要な市場プレーヤーは以下のとおりです。
・Medtronic、Stryker、Johnson and Johnson、Micro Vention、Boston Scientific、Peijia Medical、MicroPort、Shanghai Kindly Enterprise、Shandong Visee Medical

地域別セグメントは次の地域・国をカバーします。
・北米市場(米国、カナダ、メキシコ)
・ヨーロッパ市場(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋市場(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南米市場(ブラジル、アルゼンチン、コロンビア)
・中東・アフリカ市場(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、出血性神経介入装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な出血性神経介入装置メーカーの企業概要、2019年~2022年までの出血性神経介入装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な出血性神経介入装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別出血性神経介入装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの出血性神経介入装置のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での出血性神経介入装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および出血性神経介入装置の産業チェーンを掲載しています。
・第13、14、15章では、出血性神経介入装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 出血性神経介入装置の概要
- タイプ別分析(2017年vs2021年vs2028年):コイル塞栓システム、ニューロインターベンションローダイバーティングステント、その他
- アプリケーション別分析(2017年vs2021年vs2028年):病院・診療所、外来手術センター、その他
- 世界の出血性神経介入装置市場規模・予測
- 世界の出血性神経介入装置生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Medtronic、Stryker、Johnson and Johnson、Micro Vention、Boston Scientific、Peijia Medical、MicroPort、Shanghai Kindly Enterprise、Shandong Visee Medical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・タイプ別分析2017年-2028年:コイル塞栓システム、ニューロインターベンションローダイバーティングステント、その他
・アプリケーション別分析2017年-2028年:病院・診療所、外来手術センター、その他
・出血性神経介入装置の北米市場分析
- 出血性神経介入装置の北米市場:タイプ別市場規模2017年-2028年
- 出血性神経介入装置の北米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・出血性神経介入装置のヨーロッパ市場分析
- :出血性神経介入装置のヨーロッパ市場:タイプ別市場規模2017年-2028年
- :出血性神経介入装置のヨーロッパ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・出血性神経介入装置のアジア太平洋市場分析
- 出血性神経介入装置のアジア太平洋市場:タイプ別市場規模2017年-2028年
- 出血性神経介入装置のアジア太平洋市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・出血性神経介入装置の南米市場分析
- 出血性神経介入装置の南米市場:タイプ別市場規模2017年-2028年
- 出血性神経介入装置の南米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・出血性神経介入装置の中東・アフリカ市場分析
- 出血性神経介入装置の中東・アフリカ市場:タイプ別市場規模2017年-2028年
- 出血性神経介入装置の中東・アフリカ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Hemorrhagic Neurointerventional Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hemorrhagic Neurointerventional Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals and Clinics accounting for % of the Hemorrhagic Neurointerventional Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Coil Embolization System segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Hemorrhagic Neurointerventional Device include Medtronic, Stryker, Johnson and Johnson, Micro Vention, and Boston Scientific, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hemorrhagic Neurointerventional Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Coil Embolization System
Neurointervention Flow-diverting Stent
Others
Market segment by Application can be divided into
Hospitals and Clinics
Ambulatory Surgery Center
Other
The key market players for global Hemorrhagic Neurointerventional Device market are listed below:
Medtronic
Stryker
Johnson and Johnson
Micro Vention
Boston Scientific
Peijia Medical
MicroPort
Shanghai Kindly Enterprise
Shandong Visee Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hemorrhagic Neurointerventional Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hemorrhagic Neurointerventional Device, with price, sales, revenue and global market share of Hemorrhagic Neurointerventional Device from 2019 to 2022.
Chapter 3, the Hemorrhagic Neurointerventional Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemorrhagic Neurointerventional Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hemorrhagic Neurointerventional Device market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hemorrhagic Neurointerventional Device.
Chapter 13, 14, and 15, to describe Hemorrhagic Neurointerventional Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Hemorrhagic Neurointerventional Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hemorrhagic Neurointerventional Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Coil Embolization System
1.2.3 Neurointervention Flow-diverting Stent
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Hemorrhagic Neurointerventional Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgery Center
1.3.4 Other
1.4 Global Hemorrhagic Neurointerventional Device Market Size & Forecast
1.4.1 Global Hemorrhagic Neurointerventional Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Hemorrhagic Neurointerventional Device Sales in Volume (2017-2028)
1.4.3 Global Hemorrhagic Neurointerventional Device Price (2017-2028)
1.5 Global Hemorrhagic Neurointerventional Device Production Capacity Analysis
1.5.1 Global Hemorrhagic Neurointerventional Device Total Production Capacity (2017-2028)
1.5.2 Global Hemorrhagic Neurointerventional Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hemorrhagic Neurointerventional Device Market Drivers
1.6.2 Hemorrhagic Neurointerventional Device Market Restraints
1.6.3 Hemorrhagic Neurointerventional Device Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Hemorrhagic Neurointerventional Device Product and Services
2.1.4 Medtronic Hemorrhagic Neurointerventional Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Stryker
2.2.1 Stryker Details
2.2.2 Stryker Major Business
2.2.3 Stryker Hemorrhagic Neurointerventional Device Product and Services
2.2.4 Stryker Hemorrhagic Neurointerventional Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business
2.3.3 Johnson and Johnson Hemorrhagic Neurointerventional Device Product and Services
2.3.4 Johnson and Johnson Hemorrhagic Neurointerventional Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Micro Vention
2.4.1 Micro Vention Details
2.4.2 Micro Vention Major Business
2.4.3 Micro Vention Hemorrhagic Neurointerventional Device Product and Services
2.4.4 Micro Vention Hemorrhagic Neurointerventional Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Hemorrhagic Neurointerventional Device Product and Services
2.5.4 Boston Scientific Hemorrhagic Neurointerventional Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Peijia Medical
2.6.1 Peijia Medical Details
2.6.2 Peijia Medical Major Business
2.6.3 Peijia Medical Hemorrhagic Neurointerventional Device Product and Services
2.6.4 Peijia Medical Hemorrhagic Neurointerventional Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 MicroPort
2.7.1 MicroPort Details
2.7.2 MicroPort Major Business
2.7.3 MicroPort Hemorrhagic Neurointerventional Device Product and Services
2.7.4 MicroPort Hemorrhagic Neurointerventional Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Shanghai Kindly Enterprise
2.8.1 Shanghai Kindly Enterprise Details
2.8.2 Shanghai Kindly Enterprise Major Business
2.8.3 Shanghai Kindly Enterprise Hemorrhagic Neurointerventional Device Product and Services
2.8.4 Shanghai Kindly Enterprise Hemorrhagic Neurointerventional Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Shandong Visee Medical
2.9.1 Shandong Visee Medical Details
2.9.2 Shandong Visee Medical Major Business
2.9.3 Shandong Visee Medical Hemorrhagic Neurointerventional Device Product and Services
2.9.4 Shandong Visee Medical Hemorrhagic Neurointerventional Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Hemorrhagic Neurointerventional Device Breakdown Data by Manufacturer
3.1 Global Hemorrhagic Neurointerventional Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Hemorrhagic Neurointerventional Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Hemorrhagic Neurointerventional Device
3.4 Market Concentration Rate
3.4.1 Top 3 Hemorrhagic Neurointerventional Device Manufacturer Market Share in 2021
3.4.2 Top 6 Hemorrhagic Neurointerventional Device Manufacturer Market Share in 2021
3.5 Global Hemorrhagic Neurointerventional Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Hemorrhagic Neurointerventional Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hemorrhagic Neurointerventional Device Market Size by Region
4.1.1 Global Hemorrhagic Neurointerventional Device Sales in Volume by Region (2017-2028)
4.1.2 Global Hemorrhagic Neurointerventional Device Revenue by Region (2017-2028)
4.2 North America Hemorrhagic Neurointerventional Device Revenue (2017-2028)
4.3 Europe Hemorrhagic Neurointerventional Device Revenue (2017-2028)
4.4 Asia-Pacific Hemorrhagic Neurointerventional Device Revenue (2017-2028)
4.5 South America Hemorrhagic Neurointerventional Device Revenue (2017-2028)
4.6 Middle East and Africa Hemorrhagic Neurointerventional Device Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Hemorrhagic Neurointerventional Device Sales in Volume by Type (2017-2028)
5.2 Global Hemorrhagic Neurointerventional Device Revenue by Type (2017-2028)
5.3 Global Hemorrhagic Neurointerventional Device Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Hemorrhagic Neurointerventional Device Sales in Volume by Application (2017-2028)
6.2 Global Hemorrhagic Neurointerventional Device Revenue by Application (2017-2028)
6.3 Global Hemorrhagic Neurointerventional Device Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Hemorrhagic Neurointerventional Device Sales by Type (2017-2028)
7.2 North America Hemorrhagic Neurointerventional Device Sales by Application (2017-2028)
7.3 North America Hemorrhagic Neurointerventional Device Market Size by Country
7.3.1 North America Hemorrhagic Neurointerventional Device Sales in Volume by Country (2017-2028)
7.3.2 North America Hemorrhagic Neurointerventional Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Hemorrhagic Neurointerventional Device Sales by Type (2017-2028)
8.2 Europe Hemorrhagic Neurointerventional Device Sales by Application (2017-2028)
8.3 Europe Hemorrhagic Neurointerventional Device Market Size by Country
8.3.1 Europe Hemorrhagic Neurointerventional Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Hemorrhagic Neurointerventional Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Hemorrhagic Neurointerventional Device Sales by Type (2017-2028)
9.2 Asia-Pacific Hemorrhagic Neurointerventional Device Sales by Application (2017-2028)
9.3 Asia-Pacific Hemorrhagic Neurointerventional Device Market Size by Region
9.3.1 Asia-Pacific Hemorrhagic Neurointerventional Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Hemorrhagic Neurointerventional Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Hemorrhagic Neurointerventional Device Sales by Type (2017-2028)
10.2 South America Hemorrhagic Neurointerventional Device Sales by Application (2017-2028)
10.3 South America Hemorrhagic Neurointerventional Device Market Size by Country
10.3.1 South America Hemorrhagic Neurointerventional Device Sales in Volume by Country (2017-2028)
10.3.2 South America Hemorrhagic Neurointerventional Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hemorrhagic Neurointerventional Device Sales by Type (2017-2028)
11.2 Middle East & Africa Hemorrhagic Neurointerventional Device Sales by Application (2017-2028)
11.3 Middle East & Africa Hemorrhagic Neurointerventional Device Market Size by Country
11.3.1 Middle East & Africa Hemorrhagic Neurointerventional Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Hemorrhagic Neurointerventional Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Hemorrhagic Neurointerventional Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Hemorrhagic Neurointerventional Device
12.3 Hemorrhagic Neurointerventional Device Production Process
12.4 Hemorrhagic Neurointerventional Device Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Hemorrhagic Neurointerventional Device Typical Distributors
13.3 Hemorrhagic Neurointerventional Device Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer